Vivo Opportunity Fund Holdings, L.P. — SEC Form 4 filings
SEC reporting owner CIK 1930214. 7 Form 4 filings on record with FilingPulse; latest filed 2026-07-16.
Transaction summary — filings shown
Covers all 7 filings on record, filed 2024-04-03 to 2026-07-16. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 30 legs across 3 filings — 276,324 shares, $433,549 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 17 legs across 4 filings — 4,380,462 shares, $228,158,285 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 0.
- Largest priced transaction: sale of 1,100,000 shares @ $67.80 ($74,580,000) in SOLENO THERAPEUTICS INC, filed 2025-03-28.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| SOLENO THERAPEUTICS INC (SLNO) | 10% owner | 3 | — | 8 legs · 3,959,799 sh · $225,361,426 | — |
| Terns Pharmaceuticals, Inc. (TERN) | 10% owner | 1 | — | 9 legs · 420,663 sh · $2,796,859 | — |
| InMed Pharmaceuticals Inc. (INM) | 10% owner | 3 | 30 legs · 276,324 sh · $433,549 | — | — |
Form 4 filings — Vivo Opportunity Fund Holdings, L.P.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-16 | 4 | InMed Pharmaceuticals Inc. (INM) jointly with Vivo Opportunity, LLC, Vivo Opportunity Cayman, LLC, Vivo Opportunity Cayman Fund, L.P. | Purchase (P): 4,882 @ $1.55 · Purchase (P): 493 @ $1.55 · Purchase (P): 13,761 @ $1.55 · Purchase (P): 1,389 @ $1.55 · Purchase (P): 19 @ $1.55 · Purchase (P): 2 @ $1.55 | EDGAR |
| 2026-07-02 | 4 | InMed Pharmaceuticals Inc. (INM) jointly with Vivo Opportunity, LLC, Vivo Opportunity Cayman, LLC, Vivo Opportunity Cayman Fund, L.P. | Purchase (P): 545 @ $1.54 · Purchase (P): 55 @ $1.54 · Purchase (P): 3,946 @ $1.55 · Purchase (P): 398 @ $1.55 · Purchase (P): 1,460 @ $1.55 · Purchase (P): 147 @ $1.55 | EDGAR |
| 2026-06-10 | 4 | InMed Pharmaceuticals Inc. (INM) jointly with Vivo Opportunity, LLC, Vivo Opportunity Cayman, LLC, Vivo Opportunity Cayman Fund, L.P. | Purchase (P): 51,056 @ $1.56 · Purchase (P): 5,154 @ $1.56 · Purchase (P): 30,882 @ $1.69 · Purchase (P): 3,118 @ $1.69 · Purchase (P): 16,164 @ $1.57 · Purchase (P): 1,632 @ $1.57 · +12 more | EDGAR |
| 2025-03-28 | 4 | SOLENO THERAPEUTICS INC (SLNO) jointly with Vivo Opportunity, LLC | Sale (S): 400,000 @ $65.80 · Sale (S): 1,100,000 @ $67.80 · Sale (S): 333,557 @ $70.60 | EDGAR |
| 2024-08-29 | 4 | SOLENO THERAPEUTICS INC (SLNO) jointly with Vivo Opportunity, LLC | Sale (S): 500,000 @ $48.73 · Sale (S): 425,000 @ $47.35 · Sale (S): 100,000 @ $47.22 | EDGAR |
| 2024-05-01 | 4 | SOLENO THERAPEUTICS INC (SLNO) jointly with Vivo Opportunity, LLC | Sale (S): 750,000 @ $47.80 · Sale (S): 351,242 @ $45.13 | EDGAR |
| 2024-04-03 | 4 | Terns Pharmaceuticals, Inc. (TERN) jointly with Vivo Opportunity, LLC, Vivo Capital VIII, LLC, Vivo Capital Fund VIII, L.P., Vivo Capital Surplus Fund VIII, L.P. | Sale (S): 136,255 @ $6.99 · Sale (S): 39,411 @ $6.99 · Sale (S): 5,451 @ $6.99 · Sale (S): 76,346 @ $6.65 · Sale (S): 22,084 @ $6.65 · Sale (S): 3,050 @ $6.65 · +3 more | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1930214 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →